3 ms·
So long the "informed consent" really is truly informed, and not something that is slanted or otherwise concealing evidence or data. In that case, then I do no
by bradknowles 8y ago
So long the "informed consent" really is truly informed, and not something that is slanted or otherwise concealing evidence or data. In that case, then I do not disagree with you.
However, considering what we know of how PR and Marketing works, I am inclined to err on the side of "Abundance of Caution and Due Diligence", even in the face of personal responsibility.
- toomuchtodo 8y agoDefinitely. Making the marketing of pharmaceuticals directly to consumers illegal would go a long way, as well as stronger oversight and governance by regulatory bodies.